Not CRISPR data: the image illustrates antibody quality for visualizing CRISPR experiment results.
Not CRISPR data: the image illustrates antibody quality for visualizing CRISPR experiment results.
Histone Deacetylase 3 (HDAC3) Double Nickase Plasmid (m): sc-420818-NIC
- Target species: mouse
- 20 µg of transfection-ready, purified plasmid DNA; Suitable for up to 20 transfections
- Histone Deacetylase 3 (HDAC3) Double Nickase Plasmid (m) consists of a pair of plasmids each encoding a D10A mutated Cas9 nuclease and a target-specific 20 nt guide RNA (gRNA) designed to knockout gene expression with greater specificity than its CRISPR/Cas9 KO counterpart
- Paired gRNA sequences are offset by approximately 20 bp to allow for specific Cas9-mediated double nicking of the genomic DNA, which mimics a DSB
- One plasmid in the pair contains a puromycin-resistance gene for selection; the other plasmid in the pair contains a GFP marker to visually confirm transfection
- Histone Deacetylase 3 (HDAC3) Double Nickase Plasmid (m) and Histone Deacetylase 3 (HDAC3) Double Nickase Plasmid (m2) encode distinct paired gRNA designs targeting Hdac3. One or both designs may be available
- Following transfection, gene knockout efficiency can be assayed by WB, IF or IHC using antibody: Histone Deacetylase 3 (HDAC3) Antibody (A-3): sc-376957
Ordering Information
| Product Name | Catalog # | UNIT | Price | Qty | FAVORITES | |
Histone Deacetylase 3 (HDAC3) Double Nickase Plasmid (m) | sc-420818-NIC | 20 µg | $410.00 | |||
Histone Deacetylase 3 (HDAC3) Double Nickase Plasmid (m2) | sc-420818-NIC-2 | 20 µg | $410.00 |
Hdac3 encodes Histone Deacetylase 3 (HDAC3), a class I histone deacetylase that serves as a catalytic core of the NCoR/SMRT co-repressor complexes and regulates chromatin accessibility through lysine deacetylation. In mouse cells, HDAC3 coordinates transcriptional repression programs linked to cell cycle control, DNA damage responses, and metabolic homeostasis, integrating signals from nuclear receptors and inflammatory pathways. By reshaping epigenetic states, HDAC3 influences lineage commitment and tissue-specific gene expression, with perturbation associated with dysregulated proliferation and altered immune and metabolic phenotypes. These functions make Hdac3 a widely used target for studying chromatin-dependent mechanisms underlying cancer-relevant transcriptional programs, inflammation, and metabolic disease biology.
Histone Deacetylase 3 (HDAC3) Double Nickase Plasmid (m) consists of a matched pair of plasmids engineered for high-specificity editing of the Hdac3 locus in mouse cell lines. Each plasmid expresses a Cas9 D10A nickase and a distinct sgRNA targeting opposite DNA strands within Hdac3. When directed to adjacent sites on opposite DNA strands, the two nickases generate offset single-strand nicks that together produce a staggered double-strand break, requiring coordinated on-target activity from both guides. The resulting DNA break is resolved by endogenous cellular repair pathways, most commonly through non-homologous end joining (NHEJ), leading to insertions or deletions that disrupt Hdac3 function. By requiring dual sgRNA engagement at the target locus, the double nicking approach enhances editing specificity and provides a complementary CRISPR strategy for applications where additional control over targeting precision is desired.
To support efficient identification of edited cells, one plasmid encodes GFP for fluorescent visualization of transfected populations, while the companion plasmid carries a puromycin resistance gene for antibiotic selection. Together, these features support efficient enrichment of co-transfected populations and simplify the validation of Hdac3-disrupted clones.
For Research Use Only. Not Intended for Diagnostic or Therapeutic Use.